Investigator

Victor Olago

Data Manager II · National Institute for Communicable Diseases, National Cancer Registry

VOVictor Olago
Papers(1)
Cancer in HIV-positiv…
Collaborators(5)
Jabulani NcayiyanaMarcel ZwahlenMatthias EggerMazvita MuchengetiTafadzwa Dhokotera
Institutions(4)
National Health Labor…University of PretoriaBern University of Ap…University of the Wit…

Papers

Cancer in HIV-positive and HIV-negative adolescents and young adults in South Africa: a cross-sectional study

Objective To determine the spectrum of cancers in adolescents and young adults (AYAs) living with and without HIV in South Africa. Design Cross-sectional study with cancer records provided by the National Cancer Registry (NCR) and HIV records from the National Health Laboratory Service (NHLS). Setting and participants The NHLS is the largest provider of pathology services in the South African public sector. The NCR is a division of the NHLS. We included AYAs (aged 10–24 years) diagnosed with cancer by public health sector laboratories between 2004 and 2014 (n=8479). HIV status was obtained through record linkages and text mining. Primary and secondary outcomes We determined the spectrum of cancers by HIV status in AYAs. We used multivariable logistic regression to describe the association of cancer in AYAs with HIV, adjusting for age, sex, ethnicity and calendar period. We imputed (post hoc) the HIV status for AYA with unknown HIV status. Results 8479 AYAs were diagnosed with cancer, HIV status was known for 45% (n=3812). Of those whose status was known, about half were HIV positive (n=1853). AYAs living with HIV were more likely to have Kaposi’s sarcoma (adjusted OR (aOR) 218, 95% CI 89.9 to 530), cervical cancer (aOR 2.18, 95% CI 1.23 to 3.89), non-Hodgkin’s lymphoma (aOR 2.12, 95% CI 1.69 to 2.66) and anogenital cancers other than cervix (aOR 2.73, 95% CI 1.27 to 5.86) than AYAs without HIV. About 44% (n=1062) of AYAs with HIV-related cancers had not been tested for HIV. Conclusions Targeted HIV testing for AYAs diagnosed with cancer, followed by immediate start of antiretroviral therapy, screening for cervical precancer and vaccination against human papilloma virus is needed to decrease cancer burden in AYAs living with HIV in South Africa.

15Works
1Papers
5Collaborators

Positions

2017–

Data Manager II

National Institute for Communicable Diseases · National Cancer Registry

2015–

Monitoring and Evaluation Officer

Weltel MHealth International · Operations Research

2013–

Data Manager/Programmer

KEMRI/CDC Research and Public Health Collaboration · HIVR

Education

2019

Masters of Science in Epidemiology – Research Database Management

University of the Witwatersrand · School of Public Health

2013

Bachelor of Science in Information Technology

KCA University · School of Technology

2010

Diploma in Information Technology

Jomo Kenyatta University of Agriculture and Technology · School of Computing and Information Technology (SCIT)